<DOC>
	<DOC>NCT03090386</DOC>
	<brief_summary>This study is to evaluate which cognitive-linguistic symptoms are most commonly experienced following brain tumor treatment. Cognitive surveys will be administered after treatment of primary brain tumor cancer.</brief_summary>
	<brief_title>Evaluation of Cognitive-Communication Deficits Following Treatment of Primary Brain Tumor Patients</brief_title>
	<detailed_description />
	<mesh_term>Brain Neoplasms</mesh_term>
	<criteria>be between18 to 89 years old; have undergone at least one cycle of a cancer treatment regimen (e.g., chemotherapy, radiotherapy, surgery) have completed at least one cycle of a cancer treatment regimen within five years of enrollment in the study; be native speakers of American English; have obtained a minimum of a high school education; selfreport at least one cognitivelinguistic or socialemotional deficit as assessed by the FACTBR; and must demonstrate capacity to sign informed consent based on Informed Consent for Research: A Guide to Assessing a Participant's Understanding tool. are younger than 18 years old or older than 89 years old; have not undergone at least one cycle of a cancer treatment regimen following diagnosis (e.g., chemotherapy, radiotherapy, surgery) have not undergone at least one cycle of a cancer treatment regimen in the five year period prior to enrollment; are not native speakers of American English; have not obtained a minimum of a high school education; do not selfreport at least one cognitivelinguistic or socialemotional deficit as assessed by the FACTBR; or do not demonstrate the capacity to sign informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>89 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>